Kroemer G - Search Results

1

How to improve the immunogenicity of chemotherapy and radiotherapy.

Ma Y, Conforti R, Aymeric L, Locher C, Kepp O, Kroemer G, Zitvogel L. Ma Y, et al. Among authors: kroemer g. Cancer Metastasis Rev. 2011 Mar;30(1):71-82. doi: 10.1007/s10555-011-9283-2. Cancer Metastasis Rev. 2011. PMID: 21298323 Review.

2

Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA.

Marchetti P, Susin SA, Decaudin D, Gamen S, Castedo M, Hirsch T, Zamzami N, Naval J, Senik A, Kroemer G. Marchetti P, et al. Among authors: kroemer g. Cancer Res. 1996 May 1;56(9):2033-8. Cancer Res. 1996. PMID: 8616847

3

Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.

Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, Kofler R, Kroemer G. Decaudin D, et al. Among authors: kroemer g. Cancer Res. 1997 Jan 1;57(1):62-7. Cancer Res. 1997. PMID: 8988042

4

Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy (review).

Decaudin D, Marzo I, Brenner C, Kroemer G. Decaudin D, et al. Among authors: kroemer g. Int J Oncol. 1998 Jan;12(1):141-52. Int J Oncol. 1998. PMID: 9454898 Review.

5

Mitochondrion as a novel target of anticancer chemotherapy.

Costantini P, Jacotot E, Decaudin D, Kroemer G. Costantini P, et al. Among authors: kroemer g. J Natl Cancer Inst. 2000 Jul 5;92(13):1042-53. doi: 10.1093/jnci/92.13.1042. J Natl Cancer Inst. 2000. PMID: 10880547 Review.

6

Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: role of caspase-8 and mitochondria.

Ameyar-Zazoua M, Larochette N, Dorothée G, Daugas E, Haddada H, Gouloumet V, Métivier D, Stancou R, Mami-Chouaib F, Kroemer G, Chouaib S. Ameyar-Zazoua M, et al. Among authors: kroemer g. Cancer Gene Ther. 2002 Mar;9(3):219-27. doi: 10.1038/sj.cgt.7700434. Cancer Gene Ther. 2002. PMID: 11896437

7

Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C.

Schmitt E, Parcellier A, Ghiringhelli F, Casares N, Gurbuxani S, Droin N, Hamai A, Pequignot M, Hammann A, Moutet M, Fromentin A, Kroemer G, Solary E, Garrido C. Schmitt E, et al. Among authors: kroemer g. Cancer Res. 2004 Apr 15;64(8):2705-11. doi: 10.1158/0008-5472.can-03-2475. Cancer Res. 2004. PMID: 15087383

8

Immune response against dying tumor cells.

Zitvogel L, Casares N, Péquignot MO, Chaput N, Albert ML, Kroemer G. Zitvogel L, et al. Among authors: kroemer g. Adv Immunol. 2004;84:131-79. doi: 10.1016/S0065-2776(04)84004-5. Adv Immunol. 2004. PMID: 15246252 Review. No abstract available.

9

Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway.

Carvalho G, Lefaucheur C, Cherbonnier C, Métivier D, Chapel A, Pallardy M, Bourgeade MF, Charpentier B, Hirsch F, Kroemer G. Carvalho G, et al. Among authors: kroemer g. Oncogene. 2005 Jan 27;24(5):737-45. doi: 10.1038/sj.onc.1208205. Oncogene. 2005. PMID: 15580299

10

Caspase-independent cell death.

Kroemer G, Martin SJ. Kroemer G, et al. Nat Med. 2005 Jul;11(7):725-30. doi: 10.1038/nm1263. Nat Med. 2005. PMID: 16015365 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results